Pharmaceutical contract packaging organisations (CPOs) have traditionally been associated with larger CDMOs offering outsourcing solutions with full-service manufacturing capabilities from development to commercialisation, now, working with CPOs has become increasingly common, especially for those pharmaceutical companies struggling to keep up with required capabilities and budget constraints.
Lets’ explore with our Business Development and Marketing Officer Julia Leonteva the trends affecting the pharmaceutical CPO market, when and why outsourcing may be an enticing option for some, and what considerations drive outsourced packaging and drug delivery decisions.
Ready to shape the future of your pharmaceutical supply chain?